Deuterium Capital Management, LLC has released its latest 13F-HR filing, revealing its investment holdings as of September 30, 2026. This filing is significant as it provides insights into the firm's investment strategy and the sectors it prioritizes.
Founded in Clearwater, Florida, Deuterium Capital Management is an asset management firm that focuses on various investment strategies. The firm operates under the Central Index Key (CIK) number 0001860487 and is incorporated in Delaware. As per its recent filings, Deuterium has been active in reporting its holdings, with the latest submission dated November 4, 2026.
The recent filing indicates that Deuterium Capital Management holds a total investment value of approximately $93.3 million across various companies. The report includes significant positions in well-known firms such as Alphabet Inc., Amazon.com Inc., and Microsoft Corp. For instance, the firm holds 51,510 shares of Alphabet valued at approximately $17.55 million and 54,000 shares of Amazon valued at about $13.45 million.
"The filing shows that Deuterium Capital Management has a diversified portfolio with substantial investments in leading technology and healthcare companies," said Sondra Berman, Chief Compliance Officer.
In addition to tech giants, the firm has also invested in healthcare and energy sectors, including companies like Intuitive Surgical Inc. and Energy Fuels Inc. This diversification reflects a strategic approach to balancing risk and opportunity across different market segments.
Deuterium's filing may impact various stakeholders, including investors and analysts who track asset management firms. The detailed report allows for a better understanding of the firm's investment philosophy and may influence how similar firms position themselves in the market.
Looking ahead, the filing does not indicate any immediate plans for additional disclosures or changes in strategy. However, investors and industry observers will likely keep an eye on Deuterium's future filings to gauge any shifts in its investment focus.
For more information, the full filing can be accessed through the SEC's EDGAR database, under accession number 0001214659-26-013734.
Read Next
Astera Labs announces board member resignation
Xeris Biopharma reports director ownership change
Ballast Asset Management reveals latest 13F-HR filing
Alpha Wealth Funds reports Q3 holdings valued at $29.7 million
Churchill Capital Corp XI Notifies Nasdaq of Unit Removal
Liquid Strategies reports $920 million in 13F-HR filing









